Skip to main content
Premium Trial:

Request an Annual Quote

Hyseq & MicroDiscovery GmbH


Hyseq of Sunnyvale, Calif., has received US Patent Number 6,355,419, “Preparation of pools of nucleic acids based on representation in a sample.” The invention covers methods for preparing pools for use in hybridizations. Nucleic acids that are represented to a similar degree within a sample are pooled. The method allows the user to control hybridization conditions, such as temperature, ionic strength, and time, in order to increase the likelihood that the nucleic acids within each pool hybridize to a probe with an intensity that is detectable but not saturating to the probe. Additionally, the invention describes arrays and kits that include these pooled nucleic acids, as well as a method for identifying a nucleic acid within a sample.


MicroDiscovery GmbH of Berlin has received German Patent Number DE0010025384A1,”Quantitative measurement of molecule amounts in complex mixtures.” The invention described in the patent relates to a process for the quantitative measurement of molecule amounts in complex mixtures using microarrays and other analogous carriers. Fields of application for this invention are molecular biology, medicine, and the pharmaceutical industry.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.